290 related articles for article (PubMed ID: 29861410)
21. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
22. The study of multiple diagnosis models of human prostate cancer based on Taylor database by artificial neural networks.
Jiang FN; Dai LJ; Wu YD; Yang SB; Liang YX; Zhang X; Zou CY; He RQ; Xu XM; Zhong WD
J Chin Med Assoc; 2020 May; 83(5):471-477. PubMed ID: 32217993
[TBL] [Abstract][Full Text] [Related]
23. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
Chen Z; Hu H
Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
[TBL] [Abstract][Full Text] [Related]
24. Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.
Li QK; Chen J; Hu Y; Höti N; Lih TM; Thomas SN; Chen L; Roy S; Meeker A; Shah P; Chen L; Bova GS; Zhang B; Zhang H
Sci Rep; 2021 Sep; 11(1):18936. PubMed ID: 34556748
[TBL] [Abstract][Full Text] [Related]
25. Solute carrier family 16 member 5 downregulation and its methylation might serve as a prognostic indicator of prostate cancer.
Meng X; Yuan H; Li W; Xiong Z; Dong W; Xiao W; Zhang X
IUBMB Life; 2021 Nov; 73(11):1363-1377. PubMed ID: 34549875
[TBL] [Abstract][Full Text] [Related]
26. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
27. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
[TBL] [Abstract][Full Text] [Related]
28. TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.
Luo F; Yang K; Wang YZ; Lin D
Neoplasma; 2018 Sep; 65(5):815-821. PubMed ID: 30249106
[TBL] [Abstract][Full Text] [Related]
29. A Machine Learning Method for Predicting Biomarkers Associated with Prostate Cancer.
Tong Y; Tan Z; Wang P; Gao X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):333. PubMed ID: 38179769
[TBL] [Abstract][Full Text] [Related]
30. A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies.
Cheng A; Zhao S; FitzGerald LM; Wright JL; Kolb S; Karnes RJ; Jenkins RB; Davicioni E; Ostrander EA; Feng Z; Fan JB; Dai JY; Stanford JL
Prostate; 2019 Oct; 79(14):1589-1596. PubMed ID: 31376183
[TBL] [Abstract][Full Text] [Related]
31. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
[TBL] [Abstract][Full Text] [Related]
32. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.
Jhun MA; Geybels MS; Wright JL; Kolb S; April C; Bibikova M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Oncotarget; 2017 Jun; 8(26):43035-43047. PubMed ID: 28496006
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
Yu L; Toriseva M; Tuomala M; Seikkula H; Elo T; Tuomela J; Kallajoki M; Mirtti T; Taimen P; Boström PJ; Alanen K; Nurmi M; Nees M; Härkönen P
Int J Cancer; 2016 Jul; 139(1):140-52. PubMed ID: 26891277
[TBL] [Abstract][Full Text] [Related]
34. Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis.
Meng L; Li Y; Ren J; Shi T; Men J; Chang C
DNA Cell Biol; 2019 May; 38(5):468-475. PubMed ID: 30835547
[TBL] [Abstract][Full Text] [Related]
35. Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
Li R; Wang S; Cui Y; Qu H; Chater JM; Zhang L; Wei J; Wang M; Xu Y; Yu L; Lu J; Feng Y; Zhou R; Huang Y; Ma R; Zhu J; Zhong W; Jia Z
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32898860
[TBL] [Abstract][Full Text] [Related]
36. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia.
Ge Y; Wang Q; Shao W; Zhao Y; Shi Q; Yuan Q; Cui L
J Cancer; 2020; 11(15):4542-4549. PubMed ID: 32489471
[No Abstract] [Full Text] [Related]
37. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
[TBL] [Abstract][Full Text] [Related]
38. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
Fang Z; Xu S; Xie Y; Yan W
World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
[TBL] [Abstract][Full Text] [Related]
39. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]